ABT vs OTTR · P/E 25, rev $44.33B vs P/E 11, rev $677.6M
Abbott Laboratories (ABT) versus Otter Tail Corporation (OTTR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Otter Tail Corporation (OTTR) is a conglomerates company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OTTR revenue for 2026-06-30 was $677.6M. Net income was $65.0M. Revenue was up 97.6% from 2026-03-31 to 2026-06-30. OTTR currently screens at market cap $3.34B and trailing P/E 11.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OTTR currently screens at market cap $3.34B and trailing P/E 11.4.
Not investment advice. Open the ABT and OTTR stock pages for the full models.
Not investment advice.